As expected, surface protein levels of MET were reduced in MCF10A as well as in all tested basal‐like breast cancer cell lines HS578T, MDA‐MB‐468, MDA‐MB‐231, BT549, and HCC1143 upon overexpression of miR‐128‐3p (Fig. 6E). The gene discussed is MET; the disease is breast carcinoma.